Can elevated eosinophil and basophil percentages indicate ongoing antigen exposure?

Elevated levels of eosinophils and basophils are well-established clinical markers for ongoing antigen exposure, signaling that the immune system is actively responding to a perceived threat even in the absence of obvious symptoms.

Clinical and mechanistic evidence

The elevation of these specific white blood cells typically indicates a type 2 (Th2) immune response. When the body encounters antigens from allergens, parasites, or certain drugs, it activates specific pathways:

• Th2 Pathway Activation: Antigen exposure triggers CD4+ T cells to differentiate into Th2 cells, governed by the transcription factor GATA-3. These cells release interleukins, most notably IL-5, which is the primary driver for the production, activation, and recruitment of eosinophils.
• Basophil Recruitment: Cytokines like IL-4 and IL-13 facilitate the activation and recruitment of basophils. While basophils represent a small fraction of total leukocytes (typically <1%), even slight percentage increases can be clinically significant indicators of immune priming.
• Parasitic and Drug Responses: In cases of helminthic (parasitic) infections, eosinophil counts often exceed 450-500/μL, but percentage increases (frequently >5-7%) serve as a critical initial screening tool. Similarly, drug-induced hypersensitivity can cause these cells to rise before or even without significant cutaneous (skin) reactions.

Subclinical immune activation

It is biologically plausible for antigen exposure to sustain immune activation without manifesting "classic" allergy symptoms like itching, swelling, or hives.

• Subthreshold Signaling: Low-dose or chronic exposure to antigens can trigger immune cells to operate below the threshold required for a full-scale symptomatic response.
• "Kiss-and-Run" Degranulation: Research into mast cells and basophils shows they can undergo "piecemeal degranulation." Instead of a massive histamine surge, they release pro-inflammatory mediators (leukotrienes, prostaglandins) in small amounts. This sustains a state of chronic subclinical systemic inflammation (CSSI).
• Alternative Pathways: Conditions such as Mast Cell Activation Syndrome (MCAS) demonstrate that immune cells can be activated via non-IgE-mediated pathways. These pathways can drive systemic symptoms like fatigue or brain fog, which are often not recognized as "classic" allergy symptoms but reflect ongoing immune stress.

Bottom line

Elevated eosinophil and basophil percentages are scientifically validated clues for ongoing antigen exposure. This elevation indicates a sustained Th2-mediated immune state that may persist subclinically through low-level mediator release, even if traditional allergic symptoms are absent.